Discover the precision and reliability of the Supreme Peptides Retatrutide Peptide Vial, expertly formulated for advanced research applications. Each sterile vial is clearly labeled “Retatrutide” and contains a premium synthetic peptide with purity exceeding 99%, ensuring consistency and reproducibility for laboratory professionals. Intended strictly for research use only, this high-grade peptide is designed for investigative studies focused on metabolic regulation, energy balance, and weight-related signaling pathways. Packaged in a clear glass vial, it offers optimal stability, accuracy, and ease of handling in controlled research protocols.

Retatrutide is a novel multi-agonist peptide studied for its ability to simultaneously engage multiple metabolic hormone receptors involved in appetite regulation, glucose metabolism, and energy expenditure. In research settings, it has gained significant attention for its broad, integrative approach to metabolic signaling compared to single-pathway peptides.

Product overview

Retatrutide is a research-grade synthetic peptide engineered to activate GLP-1, GIP, and glucagon receptors, creating a unique tri-agonist profile. Preclinical and clinical research associate Retatrutide with enhanced metabolic efficiency, appetite modulation, and increased energy utilization. Its multi-receptor mechanism makes it a valuable tool for studying complex metabolic conditions and adaptive weight-management pathways.

Key research features

Multi-pathway metabolic signaling:
Retatrutide is widely studied for its ability to simultaneously influence satiety, insulin signaling, and energy expenditure. Research models explore how this tri-agonist activity may produce more comprehensive metabolic effects than single-receptor compounds.

Appetite and weight-regulation research:
Studies suggest Retatrutide may significantly impact hunger signaling and caloric intake through central and peripheral mechanisms, making it highly relevant in experimental research focused on obesity and body-weight regulation.

Energy expenditure and glucose metabolism:
Research indicates Retatrutide may enhance energy utilization and support glucose homeostasis by activating glucagon-related pathways alongside incretin signaling, contributing to its interest in metabolic health and endurance-related studies.

Retatrutide Suggested Use:

• Typical Dose: 3.5–12 mg per week

• Route: Subcutaneous

• Frequency: once per week or 2 times per week ( Weekly dose broken into 2 shots)

• Duration: As recommended by a healthcare professional

Note: Always consult a healthcare professional before use. Keep out of reach of children.

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.